Form 4: Actinium Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Ajit Shetty, a Director of Actinium Pharmaceuticals, Inc., reported multiple transactions in common stock on September 2, 2026.
Summary
- Grant/award: acquired 61,600 Common Stock on September 2, 2026; holds 62,357 after (Direct).
- Grant/award: acquired 92,400 Stock Option (Right to Buy) on September 2, 2026; holds 92,400 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ajit Shetty — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Grant/award | Common Stock | 61,600 | — | — | 62,357 |
| 2026-09-02 | Grant/award | Stock Option (Right to Buy) | 92,400 | — | — | 92,400 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Grant/award (61,600 shares) |
| 2026-09-02 | Grant/award (92,400 shares) |
Keywords
insider transaction, Form 4, ATNM, Actinium Pharmaceuticals, Inc., neutral, Ajit Shetty
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.